- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming Chemotherapy Resistance in Germ Cell Tumors
Authors
Keywords
-
Journal
Biomedicines
Volume 10, Issue 5, Pages 972
Publisher
MDPI AG
Online
2022-04-23
DOI
10.3390/biomedicines10050972
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA Damage Tolerance Pathways in Human Cells: A Potential Therapeutic Target
- (2022) Ashlynn Ai Li Ler et al. Frontiers in Oncology
- Diverse Roles and Targets of miRNA in the Pathogenesis of Testicular Germ Cell Tumour
- (2022) Mrinal K. Das et al. Cancers
- Pembrolizumab in Patients with Advanced Metastatic Germ Cell Tumors
- (2021) Apostolia‐Maria Tsimberidou et al. ONCOLOGIST
- Principles of signaling pathway modulation for enhancing human naive pluripotency induction
- (2021) Jonathan Bayerl et al. Cell Stem Cell
- Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
- (2021) Silvia Schmidtova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
- (2021) Silke Gillessen et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
- (2021) Jörg Beyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Are Changes in the Percentage of Specific Leukocyte Subpopulations Associated with Endogenous DNA Damage Levels in Testicular Cancer Patients?
- (2021) Katarina Kalavska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gemcitabine, carboplatin and veliparib in multiple relapsed/refractory germ cell tumours: The GCT-SK-004 phase II trial
- (2021) M. Mego et al. INVESTIGATIONAL NEW DRUGS
- Rapid Response to Pembrolizumab in a Chemo-Refractory Testicular Germ Cell Cancer with Microsatellite Instability-High
- (2021) Koji Kawai et al. OncoTargets and Therapy
- Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours
- (2020) Zuzana Cierna et al. BMC CANCER
- Targeting the Immune system and Epigenetic Landscape of Urological Tumors
- (2020) João Lobo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Olaparib as salvage treatment for advanced germ cell tumors after chemotherapy failure: Results of the open-label, single-arm, IGG-02 phase II trial.
- (2020) Ugo De Giorgi et al. JOURNAL OF CLINICAL ONCOLOGY
- Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities
- (2020) Gerda de Vries et al. CANCER TREATMENT REVIEWS
- WNT signalling in the normal human adult testis and in male germ cell neoplasms
- (2020) Julia C Young et al. HUMAN REPRODUCTION
- Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
- (2020) João Lobo et al. Cancers
- Hypermethylation and global remodeling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumors
- (2020) Zeeshan Fazal et al. Epigenetics
- Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies
- (2020) Bradley Alexander McGregor et al. CANCER
- Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
- (2019) João Lobo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigenetic treatment combinations to effectively target cisplatin‐resistant germ cell tumors‐past, present, and future considerations
- (2019) C. Oing et al. Andrology
- New insights into germ cell tumor genomics
- (2019) J.T. Lafin et al. Andrology
- A phase II study of ribociclib in men with unresectable, incurable teratoma with recent progression.
- (2019) Daniel E. Castellano et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin: The first metal based anticancer drug
- (2019) Sumit Ghosh BIOORGANIC CHEMISTRY
- Phase II study of avelumab in multiple relapsed/refractory germ cell cancer
- (2019) M. Mego et al. INVESTIGATIONAL NEW DRUGS
- Immune mechanisms and possible immune therapy in testicular germ cell tumours
- (2019) M. Chovanec et al. Andrology
- New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
- (2019) Shang-Hung Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
- (2019) Silvia Schmidtova et al. Cancers
- Testicular cancer incidence predictions in Europe 2010‐2035: a rising burden despite population ageing
- (2019) A. Znaor et al. INTERNATIONAL JOURNAL OF CANCER
- An Emerging Regulatory Role for the Tumor Microenvironment in the DNA Damage Response to Double-Strand Breaks
- (2019) Tshering D. Lama-Sherpa et al. MOLECULAR CANCER RESEARCH
- Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series
- (2019) Christoph Oing et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cancer stem cell in breast cancer therapeutic resistance
- (2018) Xupeng Bai et al. CANCER TREATMENT REVIEWS
- Epigenetics and testicular germ cell tumors
- (2018) Robert Buljubašić et al. GENE
- IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance
- (2018) Joanna Selfe et al. JOURNAL OF PATHOLOGY
- Integrated Molecular Characterization of Testicular Germ Cell Tumors
- (2018) Hui Shen et al. Cell Reports
- An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis
- (2018) Andrea Necchi et al. EUROPEAN UROLOGY
- Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group
- (2018) Martin Fenner et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems
- (2018) Hassan Dianat-Moghadam et al. JOURNAL OF CONTROLLED RELEASE
- βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors
- (2018) Michal Chovanec et al. BMC CANCER
- DNA repair pathways and cisplatin resistance: an intimate relationship
- (2018) CR Rocha et al. Clinics
- 5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells
- (2018) Christoph Oing et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors
- (2018) Daniel Nettersheim et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cancer stem cells (CSCs) in cancer progression and therapy
- (2018) Masoud Najafi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- DNA methylation profiling as a tool for testicular germ cell tumors subtyping
- (2018) Ana L Costa et al. Epigenomics
- Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation
- (2017) Stefanie Zschäbitz et al. EUROPEAN JOURNAL OF CANCER
- Brentuximab vedotin exerts profound antiproliferative and pro-apoptotic efficacy in CD30-positive as well as cocultured CD30-negative germ cell tumour cell lines
- (2017) Stefan Schönberger et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
- (2017) Andrew N. Blackford et al. MOLECULAR CELL
- Treatment of CD30‐Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases
- (2017) Costantine Albany et al. ONCOLOGIST
- Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity
- (2017) Samuel G. Awuah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Current Management of Refractory Germ Cell Tumors and Future Directions
- (2017) J. Clayton Allen et al. Current Oncology Reports
- Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours
- (2017) Christiane Rudolph et al. CELLULAR ONCOLOGY
- Exploring the molecular aspects associated with testicular germ cell tumors: a review
- (2017) Gaetano Facchini et al. Oncotarget
- Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors
- (2017) Michal Chovanec et al. Oncotarget
- Chemotherapy-Induced Depletion of OCT4-Positive Cancer Stem Cells in a Mouse Model of Malignant Testicular Cancer
- (2017) Timothy M. Pierpont et al. Cell Reports
- Deep exploration of the immune infiltrate and outcome prediction in testicular cancer by quantitative multiplexed immunohistochemistry and gene expression profiling
- (2017) Peter J. Siska et al. OncoImmunology
- Cytokines in Male Fertility and Reproductive Pathologies: Immunoregulation and Beyond
- (2017) Kate L. Loveland et al. Frontiers in Endocrinology
- Antitumor activity of brentuximab vedotin in CD30 positive refractory germ cell tumors.
- (2017) Costantine Albany et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib monotherapy in patients with inoperable/recurrent germ cell tumors (GCT) refractory to chemotherapy: Phase II study.
- (2017) Iwona Anna Skoneczna et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of nintedanib in germ cell tumors
- (2016) Gustav Steinemann et al. ANTI-CANCER DRUGS
- The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas
- (2016) Daniel Nettersheim et al. BRITISH JOURNAL OF CANCER
- Brentuximab Vedotin in CD30-Expressing Germ Cell Tumors After Chemotherapy Failure
- (2016) Andrea Necchi et al. Clinical Genitourinary Cancer
- Epigenetic Targeting of Platinum Resistant Testicular Cancer
- (2016) Daniel Sonnenburg et al. CURRENT CANCER DRUG TARGETS
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- (2016) Holger Moch et al. EUROPEAN UROLOGY
- Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells
- (2016) Mirjam Gerwing et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ATM and ATR signaling at a glance
- (2016) Poorwa Awasthi et al. JOURNAL OF CELL SCIENCE
- The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo
- (2016) Sina Jostes et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
- (2016) Aditya Bagrodia et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic evolution and chemoresistance in germ-cell tumours
- (2016) Amaro Taylor-Weiner et al. NATURE
- Phase II study of everolimus in refractory testicular germ cell tumors
- (2016) Michal Mego et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care—Registry data from an outcomes research project of the German Testicular Cancer Study Group
- (2016) Christoph Seidel et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment
- (2016) Daniel Nettersheim et al. Oncotarget
- MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients
- (2016) Camila Maria da Silva Martinelli et al. Oncotarget
- Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
- (2016) Costantine Albany et al. Oncotarget
- mTOR expression in human testicular seminoma
- (2015) A. Yaba et al. ANDROLOGIA
- Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
- (2015) Z. Cierna et al. ANNALS OF ONCOLOGY
- Frequent PD-L1 expression in testicular germ cell tumors
- (2015) C D Fankhauser et al. BRITISH JOURNAL OF CANCER
- Comprehensive identification of genes driven by ERV9-LTRs reveals TNFRSF10B as a re-activatable mediator of testicular cancer cell death
- (2015) U Beyer et al. CELL DEATH AND DIFFERENTIATION
- The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
- (2015) Vicki Plaks et al. Cell Stem Cell
- Current chemotherapeutic approaches for recurrent or refractory germ cell tumors
- (2015) Brent O׳Carrigan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Expression of the copper transporters hCtr1, ATP7A and ATP7B is associated with the response to chemotherapy and survival time in patients with resected non-small cell lung cancer
- (2015) TIAN YANG et al. Oncology Letters
- ALDH1A1 expression correlates with clinicopathologic features and poor prognosis of breast cancer patients: a systematic review and meta-analysis
- (2014) Ying Liu et al. BMC CANCER
- Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors
- (2014) David J. Vaughn et al. CANCER
- Presence of Somatic Mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in Cisplatin-Resistant Germ Cell Tumors
- (2014) D. R. Feldman et al. CLINICAL CANCER RESEARCH
- DNA repair diseases: what do they tell us about cancer and aging?
- (2014) Carlos FM Menck et al. GENETICS AND MOLECULAR BIOLOGY
- Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial
- (2014) Vivek Subbiah et al. Journal of Hematology & Oncology
- Cisplatin Induces Resistance by Triggering Differentiation of Testicular Embryonal Carcinoma Cells
- (2014) Paolo B. Abada et al. PLoS One
- Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors
- (2013) Mercè Juliachs et al. BMC CANCER
- Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours
- (2013) J Mendoza et al. BRITISH JOURNAL OF CANCER
- Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4
- (2013) M. Gutekunst et al. CANCER RESEARCH
- The PDGFRβ–AKT Pathway Contributes to CDDP-Acquired Resistance in Testicular Germ Cell Tumors
- (2013) M. Juliachs et al. CLINICAL CANCER RESEARCH
- Combination of Paclitaxel, Cisplatin, and Gemcitabine (TPG) for Multiple Relapses or Platinum-Resistant Germ Cell Tumors: Long-Term Outcomes
- (2013) Andrea Necchi et al. Clinical Genitourinary Cancer
- Long-term survival in patients with germ cell testicular cancer: A population-based competing-risks regression analysis
- (2013) G. Gandaglia et al. EJSO
- Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer
- (2013) R. Koster et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Aldehyde dehydrogenasehigh gastric cancer stem cells are resistant to chemotherapy
- (2013) SHIMPEI NISHIKAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors
- (2013) Darren R. Feldman et al. INVESTIGATIONAL NEW DRUGS
- Salvage Chemotherapy with Docetaxel, Ifosfamide and Nedaplatin (DIN) for Patients with Advanced Germ Cell Tumors: A Preliminary Report
- (2013) S. Yamada et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-302a sensitizes testicular embryonal carcinoma cells to cisplatin-induced cell death
- (2013) Lin Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- PARP expression in germ cell tumours
- (2013) Michal Mego et al. JOURNAL OF CLINICAL PATHOLOGY
- Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines
- (2013) Friedemann Honecker et al. Journal of Proteomics
- Persistent CD30 Expression by Embryonal Carcinoma in the Treatment Time Course: Prognostic Significance of a Worthwhile Target for Personalized Treatment
- (2013) Patrizia Giannatempo et al. JOURNAL OF UROLOGY
- Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer
- (2012) B Nitzsche et al. BRITISH JOURNAL OF CANCER
- Chemotherapeutic Sensitivity of Testicular Germ Cell Tumors Under Hypoxic Conditions Is Negatively Regulated by SENP1-Controlled Sumoylation of OCT4
- (2012) Y.-C. Wu et al. CANCER RESEARCH
- Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent
- (2012) Alessandra di Pietro et al. CELL CYCLE
- Understanding cancer stem cell heterogeneity and plasticity
- (2012) Dean G Tang CELL RESEARCH
- Transcription Factors Sp1 and p73 Control the Expression of the Proapoptotic Protein NOXA in the Response of Testicular Embryonal Carcinoma Cells to Cisplatin
- (2012) Lara Grande et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome
- (2012) Xiao Li et al. Journal of Thoracic Oncology
- The DNA damage response and cancer therapy
- (2012) Christopher J. Lord et al. NATURE
- Sunitinib in Patients with Cisplatin-Refractory Germ Cell Tumors
- (2012) Maria Reckova et al. ONKOLOGIE
- Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation
- (2012) Bijesh K. Biswal et al. PLoS One
- Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition
- (2012) Francesca Cavallo et al. PLoS One
- Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
- (2011) K. Oechsle et al. ANNALS OF ONCOLOGY
- DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma
- (2011) M Brait et al. BRITISH JOURNAL OF CANCER
- Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
- (2011) M Yamasaki et al. BRITISH JOURNAL OF CANCER
- Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design
- (2011) Darren R. Feldman et al. CANCER
- Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors
- (2011) Karin Oechsle et al. EUROPEAN UROLOGY
- The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression
- (2011) Daniel Nettersheim et al. GENES CHROMOSOMES & CANCER
- Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
- (2011) Matthias Port et al. Molecular Cancer
- Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells
- (2011) Derk ten Berge et al. NATURE CELL BIOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Brief Report: Phase II Multicenter Study of Temozolomide in Patients with Cisplatin-Resistant Germ Cell Tumors
- (2011) P. Maroto et al. ONCOLOGY
- p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin
- (2011) Matthias Gutekunst et al. PLoS One
- Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway
- (2011) R Koster et al. Cell Death & Disease
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers
- (2010) Elodie E. Noel et al. AMERICAN JOURNAL OF PATHOLOGY
- Malignant Germ Cell Tumors Display Common MicroRNA Profiles Resulting in Global Changes in Expression of Messenger RNA Targets
- (2010) Roger D. Palmer et al. CANCER RESEARCH
- Mechanism of p53 stabilization by ATM after DNA damage
- (2010) Qian Cheng et al. CELL CYCLE
- Expression of EGFR, HER-2/neu and KIT in germ cell tumours
- (2010) Ignacio Durán et al. Clinical & Translational Oncology
- Therapeutic Targeting of the DNA Mismatch Repair Pathway
- (2010) S. A. Martin et al. CLINICAL CANCER RESEARCH
- The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin
- (2010) Anamaria Brozovic et al. CRITICAL REVIEWS IN TOXICOLOGY
- Histological evidence for the existence of germ cell tumor cells showing embryonal carcinoma morphology but lacking OCT4 expression and cisplatin sensitivity
- (2010) Thomas Mueller et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Salvage chemotherapy with methotrexate, etoposide and actinomycin D in men with metastatic nonseminomatous germ cell tumors with a choriocarcinoma component: A preliminary report
- (2010) Tomoaki Terakawa et al. INTERNATIONAL JOURNAL OF UROLOGY
- Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
- (2010) Roelof Koster et al. JOURNAL OF CLINICAL INVESTIGATION
- TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis
- (2010) Darren R. Feldman et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance
- (2010) Hendrik Wermann et al. JOURNAL OF PATHOLOGY
- Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
- (2010) Svetlana Usanova et al. Molecular Cancer
- Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma
- (2010) Wakai ONCOLOGY REPORTS
- Long-term results of a combination of paclitaxel, cisplatin and gemcitabine for salvage therapy in male germ-cell tumours
- (2009) Nicola Nicolai et al. BJU INTERNATIONAL
- High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
- (2009) M. J. Beyrouthy et al. CANCER RESEARCH
- Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors
- (2009) W. Castillo-Avila et al. CLINICAL CANCER RESEARCH
- Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals
- (2009) Sigal Shachar et al. EMBO JOURNAL
- Synthetic lethal targeting ofPTENmutant cells with PARP inhibitors
- (2009) Ana M. Mendes-Pereira et al. EMBO Molecular Medicine
- Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours
- (2009) Sebastian Bauer et al. EUROPEAN UROLOGY
- Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
- (2009) Darren R. Feldman et al. INVESTIGATIONAL NEW DRUGS
- Microsatellite Instability, Mismatch Repair Deficiency, andBRAFMutation in Treatment-Resistant Germ Cell Tumors
- (2009) Friedemann Honecker et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Growing Teratoma Syndrome
- (2009) David J. Vaughn et al. NEW ENGLAND JOURNAL OF MEDICINE
- ERCC1 and XPF expression in human testicular germ cell tumors
- (2009) Köberle ONCOLOGY REPORTS
- Cisplatin Cytotoxicity: DNA and Plasma Membrane Targets
- (2008) Amelie Rebillard et al. CURRENT MEDICINAL CHEMISTRY
- Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors
- (2008) Georges J Netto et al. MODERN PATHOLOGY
- The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs
- (2008) C. A. Larson et al. MOLECULAR PHARMACOLOGY
- Mutations of c-kit gene in bilateral testicular germ cell tumours in Japan
- (2007) Yuji Sakuma et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started